Andrea E. Dunaif - Publications

Affiliations: 
Neuroscience Institute Graduate Program Northwestern University, Evanston, IL 
Area:
Endocrinology Biology, Physiology Biology, Neuroscience Biology

149 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Dapas M, Dunaif A. Deconstructing a Syndrome: Genomic Insights into PCOS Causal Mechanisms and Classification. Endocrine Reviews. PMID 35026001 DOI: 10.1210/endrev/bnac001  0.338
2020 Qin L, Zhao S, Yang P, Cao Y, Zhang J, Chen ZJ, Dunaif A, Zhao H. Variation analysis of anti-Müllerian hormone gene in Chinese women with polycystic ovary syndrome. Endocrine. PMID 33169290 DOI: 10.1007/s12020-020-02538-4  0.331
2020 Torchen LC, Sisk R, Legro RS, Turcu AF, Auchus RJ, Dunaif A. 11-Oxygenated C19 Steroids Do Not Distinguish the Hyperandrogenic Phenotype of PCOS Daughters from Girls with Obesity. The Journal of Clinical Endocrinology and Metabolism. 105. PMID 32797203 DOI: 10.1210/Clinem/Dgaa532  0.364
2020 Dapas M, Lin FTJ, Nadkarni GN, Sisk R, Legro RS, Urbanek M, Hayes MG, Dunaif A. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. Plos Medicine. 17: e1003132. PMID 32574161 DOI: 10.1371/Journal.Pmed.1003132  0.375
2020 Dapas M, Dunaif A. The contribution of rare genetic variants to the pathogenesis of polycystic ovary syndrome. Current Opinion in Endocrine and Metabolic Research. 12: 26-32. PMID 32440573 DOI: 10.1016/J.Coemr.2020.02.011  0.325
2020 Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S, Lindgren CM, Welt CK, Diamanti-Kandarakis E, Panidis D, Goodarzi MO, ... ... Dunaif A, et al. Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nature Communications. 11: 2158. PMID 32345980 DOI: 10.1038/S41467-020-15793-W  0.319
2020 Palomaki GE, Kalra B, Kumar T, Patel AS, Savjani G, Torchen LC, Dunaif A, Morrison A, Lambert-Messerlian GM, Kumar A. Adjusting anti-Müllerian hormone levels for age and body mass index improves detection of polycystic ovary syndrome. Fertility and Sterility. PMID 32147175 DOI: 10.1016/J.Fertnstert.2019.12.012  0.385
2020 Torchen LC, Ratnam S, Vendrami C, Miller F, Dunaif AE. OR11-02 Distinctive Neuroendocrine Changes and Menstrual Dysfunction in Early Postmenarchal Daughters of Women With PCOS Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.2172  0.37
2019 Torchen LC, Tsai JN, Jasti P, Macaya R, Sisk R, Dapas ML, Hayes MG, Urbanek M, Dunaif A. Hyperandrogenemia is Common in Asymptomatic Women and is Associated with Increased Metabolic Risk. Obesity (Silver Spring, Md.). PMID 31729166 DOI: 10.1002/Oby.22659  0.443
2019 Dapas M, Sisk R, Legro RS, Urbanek M, Dunaif A, Hayes MG. Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. PMID 31038695 DOI: 10.1210/Jc.2018-02496  0.429
2018 Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Huang H, Broer L, Magi R, Saxena R, Laisk T, Urbanek M, Hayes MG, ... ... Dunaif A, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. Plos Genetics. 14: e1007813. PMID 30566500 DOI: 10.1371/Journal.Pgen.1007813  0.466
2018 Zhao J, Xu J, Wang W, Zhao H, Liu H, Liu X, Liu J, Sun Y, Dunaif A, Du Y, Chen ZJ. Long non-coding RNA LINC-01572:28 inhibits granulosa cell growth via a decrease in p27 (Kip1) degradation in patients with polycystic ovary syndrome. Ebiomedicine. PMID 30293818 DOI: 10.1016/J.Ebiom.2018.09.043  0.339
2018 Li M, Zhao H, Zhao SG, Wei DM, Zhao YR, Huang T, Muhammad T, Yan L, Gao F, Li L, Lu G, Dunaif A, Liu HB, Chen ZJ. The HMGA2-IMP2 Pathway Promotes Granulosa Cell Proliferation in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism. PMID 30247605 DOI: 10.1210/Jc.2018-00544  0.35
2017 Sam S, Vellanki P, Yalamanchi SK, Bergman RN, Dunaif A. Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome. Metabolism: Clinical and Experimental. 71: 125-131. PMID 28521865 DOI: 10.1016/J.Metabol.2017.03.008  0.44
2017 Gorsic LK, Kosova G, Werstein B, Sisk R, Legro RS, Hayes MG, Teixeira JM, Dunaif A, Urbanek M. Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism. PMID 28505284 DOI: 10.1210/Jc.2017-00612  0.403
2016 Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism. 102: 604-612. PMID 27906550 DOI: 10.1210/Jc.2016-2963  0.343
2016 Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nature Reviews. Disease Primers. 2: 16057. PMID 27510637 DOI: 10.1038/nrdp.2016.57  0.329
2016 Torchen LC, Kumar A, Kalra B, Savjani G, Sisk R, Legro RS, Dunaif A. Increased antimüllerian hormone levels and other reproductive endocrine changes in adult male relatives of women with polycystic ovary syndrome. Fertility and Sterility. PMID 27042970 DOI: 10.1016/J.Fertnstert.2016.03.029  0.453
2016 Torchen LC, Idkowiak J, Fogel NR, O'Neil DM, Shackleton CHL, Arlt W, Dunaif A. Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism. 101: 2069-2075. PMID 26990942 DOI: 10.1210/Jc.2015-3926  0.42
2016 Dunaif A. Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity The Journal of Clinical Endocrinology and Metabolism. 101: 759-768. PMID 26908109 DOI: 10.1210/Jc.2015-3780  0.44
2015 Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S, Lindgren CM, Welt CK, Diamanti-Kandarakis E, Panidis D, Goodarzi MO, ... ... Dunaif A, et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nature Communications. 6: 7502. PMID 26284813 DOI: 10.1038/Ncomms8502  0.467
2014 Liu DM, Torchen LC, Sung Y, Paparodis R, Legro RS, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Human Reproduction (Oxford, England). 29: 2764-72. PMID 25336708 DOI: 10.1093/Humrep/Deu282  0.466
2014 Torchen LC, Fogel NR, Brickman WJ, Paparodis R, Dunaif A. Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives. The Journal of Clinical Endocrinology and Metabolism. 99: 3855-3862. PMID 25029420 DOI: 10.1210/Jc.2014-1474  0.497
2014 Kobaly K, Vellanki P, Sisk RK, Armstrong L, Lee JY, Lee J, Hayes MG, Urbanek M, Legro RS, Dunaif A. Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 99: 2961-6. PMID 24878041 DOI: 10.1210/Jc.2013-4338  0.426
2013 Dunaif AE, Fauser BCJM. Renaming PCOS--a two-state solution. The Journal of Clinical Endocrinology and Metabolism. 98: 4325-4328. PMID 24009134 DOI: 10.1210/Jc.2013-2040  0.446
2013 Sasidevi A, Vellanki P, Kunselman AR, Raja-Khan N, Dunaif A, Legro RS. Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome. Human Reproduction (Oxford, England). 28: 770-6. PMID 23257395 DOI: 10.1093/Humrep/Des416  0.38
2013 Kuang H, Vellanki P, Dodson WC, Kunselman AR, Dunaif A, Legro RS. Fasting glucose levels do not predict impaired glucose tolerance (IGT) in polycystic ovary synrome (PCOS) Fertility and Sterility. 100. DOI: 10.1016/J.Fertnstert.2013.07.853  0.341
2012 Diamanti-Kandarakis E, Dunaif A. Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications Endocrine Reviews. 33: 981-1030. PMID 23065822 DOI: 10.1210/Er.2011-1034  0.512
2012 Layden BT, Yalamanchi SK, Wolever TM, Dunaif A, Lowe WL. Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 5: 49-55. PMID 22419881 DOI: 10.2147/Dmso.S29244  0.393
2012 Yalamanchi SK, Sam S, Cardenas MO, Holaday LW, Urbanek M, Dunaif A. Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS. Obesity (Silver Spring, Md.). 20: 1273-8. PMID 22301903 DOI: 10.1038/Oby.2011.400  0.474
2012 Marshall JC, Dunaif A. Should all women with PCOS be treated for insulin resistance? Fertility and Sterility. 97: 18-22. PMID 22192137 DOI: 10.1016/J.Fertnstert.2011.11.036  0.507
2012 Dunaif A. Polycystic ovary syndrome in 2011: Genes, aging and sleep apnea in polycystic ovary syndrome. Nature Reviews Endocrinology. 8: 72-74. PMID 22183129 DOI: 10.1038/Nrendo.2011.227  0.435
2012 Goodarzi MO, Jones MR, Li X, Chua AK, Garcia OA, Chen YD, Krauss RM, Rotter JI, Ankener W, Legro RS, Azziz R, Strauss JF, Dunaif A, Urbanek M. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. Journal of Medical Genetics. 49: 90-5. PMID 22180642 DOI: 10.1136/Jmedgenet-2011-100427  0.377
2012 Hill LD, Ewens KG, Maher BS, York TP, Legro RS, Dunaif A, Strauss JF. Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Molecular and Cellular Endocrinology. 350: 72-7. PMID 22178088 DOI: 10.1016/J.Mce.2011.11.022  0.403
2012 Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JSE, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group Fertility and Sterility. 97: 28-38.e25. PMID 22153789 DOI: 10.1016/J.Fertnstert.2011.09.024  0.402
2012 Jasti P, Dunaif A. Reproduction and Metabolism: Insights from Polycystic Ovary Syndrome Endocrinology and Metabolism. 27: 180-190. DOI: 10.3803/Enm.2012.27.3.180  0.526
2011 Paparodis R, Dunaif A. The Hirsute woman: challenges in evaluation and management. Endocrine Practice. 17: 807-818. PMID 21856600 DOI: 10.4158/Ep11117.Ra  0.364
2011 Bentley-Lewis R, Seely E, Dunaif A. Ovarian Hypertension: Polycystic Ovary Syndrome Endocrinology and Metabolism Clinics of North America. 40: 433-449. PMID 21565677 DOI: 10.1016/J.Ecl.2011.01.009  0.375
2011 Taylor MC, Reema Kar A, Kunselman AR, Stetter CM, Dunaif A, Legro RS. Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. Human Reproduction (Oxford, England). 26: 2226-31. PMID 21505042 DOI: 10.1093/Humrep/Der101  0.408
2011 Ewens KG, Jones MR, Ankener W, Stewart DR, Urbanek M, Dunaif A, Legro RS, Chua A, Azziz R, Spielman RS, Goodarzi MO, Strauss JF. Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertility and Sterility. 95: 2538-41.e1-6. PMID 21444075 DOI: 10.1016/J.Fertnstert.2011.02.050  0.391
2011 Ewens KG, Jones MR, Ankener W, Stewart DR, Urbanek M, Dunaif A, Legro RS, Chua A, Azziz R, Spielman RS, Goodarzi MO, Strauss JF. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. Plos One. 6: e16390. PMID 21283731 DOI: 10.1371/Journal.Pone.0016390  0.412
2011 Wickham EP, Ewens KG, Legro RS, Dunaif AE, Nestler JE, Strauss JF. Polymorphisms in the SHBG Gene Influence Serum SHBG Levels in Women with Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 96. PMID 21252242 DOI: 10.1210/Jc.2010-1842  0.37
2011 Park CJ, Zhao Z, Glidewell-Kenney C, Lazic M, Chambon P, Krust A, Weiss J, Clegg DJ, Dunaif A, Jameson JL, Levine JE. Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice. The Journal of Clinical Investigation. 121: 604-12. PMID 21245576 DOI: 10.1172/Jci41702  0.639
2011 Lazic M, Aird F, Levine JE, Dunaif A. Prenatal androgen treatment alters body composition and glucose homeostasis in male rats. The Journal of Endocrinology. 208: 293-300. PMID 21173020 DOI: 10.1677/Joe-10-0263  0.665
2010 Abbott DH, Bruns CR, Barnett DK, Dunaif A, Goodfriend TL, Dumesic DA, Tarantal AF. Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring. American Journal of Physiology. Endocrinology and Metabolism. 299: E741-51. PMID 20682841 DOI: 10.1152/Ajpendo.00058.2010  0.427
2010 Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. The Journal of Clinical Endocrinology and Metabolism. 95: 2180-6. PMID 20228162 DOI: 10.1210/Jc.2009-2651  0.435
2010 Ewens KG, Stewart DR, Ankener W, Urbanek M, McAllister JM, Chen C, Baig KM, Parker SC, Margulies EH, Legro RS, Dunaif A, Strauss JF, Spielman RS. Family-based analysis of candidate genes for polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 95: 2306-15. PMID 20200332 DOI: 10.1210/Jc.2009-2703  0.355
2010 Legro RS, Roller RL, Dodson WC, Stetter CM, Kunselman AR, Dunaif A. Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives. The Journal of Clinical Endocrinology and Metabolism. 95: 789-99. PMID 19965924 DOI: 10.1210/Jc.2009-1849  0.402
2010 Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels Obstetrical & Gynecological Survey. 65: 773-774. DOI: 10.1097/Ogx.0B013E31821344F0  0.393
2010 Ewens KG, Stewart DR, Ankener W, Urbanek M, McAllister JM, Chen C, Baig KM, Parker SCJ, Margulies EH, Legro RS, Dunaif A, Strauss JF, Spielman RS. Family-based analysis of candidate genes for polycystic ovary syndrome Obstetrical & Gynecological Survey. 65: 571-572. DOI: 10.1097/Ogx.0B013E3182021Dfd  0.353
2009 Coviello AD, Sam S, Legro RS, Dunaif A. High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity Journal of Clinical Endocrinology and Metabolism. 94: 4361-4366. PMID 19837913 DOI: 10.1210/Jc.2009-1333  0.446
2009 Chen C, Wickenheisser J, Ewens KG, Ankener W, Legro RS, Dunaif A, McAllister JM, Spielman RS, Strauss JF. PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women. Molecular Human Reproduction. 15: 459-69. PMID 19482904 DOI: 10.1093/Molehr/Gap035  0.347
2009 Urbanek M, Nampiaparampil G, D'Souza J, Sefton E, Ackerman C, Legro RS, Dunaif A. The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 94: 2665-9. PMID 19401371 DOI: 10.1210/Jc.2008-2704  0.472
2009 Biyasheva A, Legro RS, Dunaif A, Urbanek M. Evidence for Association between Polycystic Ovary Syndrome (PCOS) and TCF7L2 and Glucose Intolerance in Women with PCOS and TCF7L2 The Journal of Clinical Endocrinology and Metabolism. 94: 2617-2625. PMID 19351735 DOI: 10.1210/Jc.2008-1664  0.527
2009 Hultgren S, Goldstein JM, Delancey JO, Bandstra ES, Brady KT, Brown JS, Deng HW, Dunaif A, Ehrmann DA, Mayer EA, Sinha R, Tobet S, Levine JE. The vital role of ORWH. Science (New York, N.Y.). 323: 1009-10. PMID 19229019 DOI: 10.1126/Science.323.5917.1009C  0.327
2009 Urbanek M, Nampiaparampil G, D'Souza J, Sefton E, Ackerman C, Legro RS, Dunaif A. The Role of Genetic Variation in the Lamin A/C Gene in the Etiology of Polycystic Ovary Syndrome Molecular Endocrinology. 23: 1124-1124. DOI: 10.1210/Mend.23.7.9999  0.331
2009 Chen C, Wickenheisser J, Ewens KG, Ankener W, Legro RS, Dunaif A, McAllister JM, Spielman RS, Strauss JF. PDE8A Genetic Variation Is Not Associated with Polycystic Ovary Syndrome. Biology of Reproduction. 81: 364-364. DOI: 10.1093/Biolreprod/81.S1.364  0.359
2008 Demissie M, Lazic M, Foecking EM, Aird F, Dunaif A, Levine JE. Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. American Journal of Physiology. Endocrinology and Metabolism. 295: E262-8. PMID 18544644 DOI: 10.1152/Ajpendo.90208.2008  0.695
2008 Dunaif A. Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal. Nature Clinical Practice Endocrinology & Metabolism. 4: 272-283. PMID 18364705 DOI: 10.1038/Ncpendmet0787  0.454
2008 Sam S, Coviello AD, Sung YA, Legro RS, Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome Diabetes Care. 31: 1237-1241. PMID 18332151 DOI: 10.2337/Dc07-2190  0.509
2008 Sam S, Sung YA, Legro RS, Dunaif A. Evidence for pancreatic β-cell dysfunction in brothers of women with polycystic ovary syndrome Metabolism: Clinical and Experimental. 57: 84-89. PMID 18078863 DOI: 10.1016/J.Metabol.2007.08.010  0.534
2008 Urbanek M, Sam S, Legro RS, Dunaif A. Identification of a Polycystic Ovary Syndrome Susceptibility Variant in Fibrillin-3 and Association With a Metabolic Phenotype Obstetrical & Gynecological Survey. 63: 311-312. DOI: 10.1097/01.Ogx.0000312155.17603.54  0.505
2007 Urbanek M, Sam S, Legro RS, Dunaif A. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype Journal of Clinical Endocrinology and Metabolism. 92: 4191-4198. PMID 17785364 DOI: 10.1210/Jc.2007-0761  0.531
2007 Corbould A, Dunaif A. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome Metabolism-Clinical and Experimental. 56: 716-722. PMID 17445549 DOI: 10.1016/J.Metabol.2006.12.021  0.472
2007 Beckman JA, Goldfine AB, Dunaif A, Gerhard-Herman M, Creager MA. Endothelial function varies according to insulin resistance disease type Diabetes Care. 30: 1226-1232. PMID 17261751 DOI: 10.2337/Dc06-2142  0.388
2007 Stewart DR, Dombroski BA, Urbanek M, Ankener W, Ewens KG, Wood JR, Legro RS, Strauss JF, Dunaif A, Spielman RS. Fine Mapping of Genetic Susceptibility to Polycystic Ovary Syndrome on Chromosome 19p13.2 and Tests for Regulatory Activity Obstetrical & Gynecological Survey. 62: 184-185. DOI: 10.1097/01.Ogx.0000256747.15722.C0  0.306
2006 Stewart DR, Dombroski BA, Urbanek M, Ankener W, Ewens KG, Wood JR, Legro RS, Strauss JF, Dunaif A, Spielman RS. Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity The Journal of Clinical Endocrinology and Metabolism. 91: 4112-4117. PMID 16868051 DOI: 10.1210/Jc.2006-0951  0.313
2006 Dunaif A. Insulin resistance in women with polycystic ovary syndrome Fertility and Sterility. 86. PMID 16798274 DOI: 10.1016/J.Fertnstert.2006.04.011  0.511
2006 Sam S, Legro RS, Essah PA, Apridonidze T, Dunaif A. Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome Proceedings of the National Academy of Sciences of the United States of America. 103: 7030-7035. PMID 16632599 DOI: 10.1073/Pnas.0602025103  0.477
2006 Corbould A, Zhao H, Mirzoeva S, Aird F, Dunaif A. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes. 55: 751-9. PMID 16505239 DOI: 10.2337/Diabetes.55.03.06.Db05-0453  0.424
2006 Coviello AD, Legro RS, Dunaif A. Adolescent Girls with Polycystic Ovary Syndrome Have an Increased Risk of the Metabolic Syndrome Associated with Increasing Androgen Levels Independent of Obesity and Insulin Resistance The Journal of Clinical Endocrinology and Metabolism. 91: 492-497. PMID 16249280 DOI: 10.1210/Jc.2005-1666  0.374
2005 Ho CK, Wood JR, Stewart DR, Ewens K, Ankener W, Wickenheisser J, Nelson-Degrave V, Zhang Z, Legro RS, Dunaif A, McAllister JM, Spielman R, Strauss JF. Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells. The Journal of Clinical Endocrinology and Metabolism. 90: 6596-602. PMID 16159937 DOI: 10.1210/Jc.2005-0890  0.315
2005 Urbanek M, Woodroffe A, Ewens KG, Diamanti-Kandarakis E, Legro RS, Strauss JF, Dunaif AE, Spielman RS. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. The Journal of Clinical Endocrinology and Metabolism. 90: 6623-6629. PMID 16091490 DOI: 10.1210/Jc.2005-0622  0.316
2005 Sam S, Legro RS, Bentley-Lewis R, Dunaif A. Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism. 90: 4797-4802. PMID 15899949 DOI: 10.1210/Jc.2004-2217  0.484
2005 Legro RS, Gnatuk CL, Kunselman AR, Dunaif AE. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. The Journal of Clinical Endocrinology and Metabolism. 90: 3236-3242. PMID 15797965 DOI: 10.1210/Jc.2004-1843  0.445
2005 Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. The Journal of Clinical Endocrinology and Metabolism. 90: 2571-9. PMID 15713728 DOI: 10.1210/Jc.2004-0219  0.478
2005 Corbould A, Kim YB, Youngren JF, Pender C, Kahn BB, Lee A, Dunaif A. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. American Journal of Physiology. Endocrinology and Metabolism. 288: E1047-54. PMID 15613682 DOI: 10.1152/Ajpendo.00361.2004  0.495
2005 Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype Obstetrical and Gynecological Survey. 60: 802-803. DOI: 10.1097/01.Ogx.0000189150.81274.A6  0.517
2004 Azziz R, Dunaif A, Ehrmann D. Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 89: 0-0. DOI: 10.1210/Jcem.89.9.9990  0.382
2003 Sam S, Dunaif A. Polycystic ovary syndrome: Syndrome XX? Trends in Endocrinology and Metabolism. 14: 365-370. PMID 14516934 DOI: 10.1016/J.Tem.2003.08.002  0.497
2003 Dunaif A. Hyperandrogenemia is neceesary but not sufficient for polycystic ovary syndrome Fertility and Sterility. 80: 262-263. PMID 12909482 DOI: 10.1016/S0015-0282(03)00732-5  0.382
2003 Urbanek M, Du Y, Silander K, Collins FS, Steppan CM, Strauss JF, Dunaif A, Spielman RS, Legro RS. Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes. 52: 214-7. PMID 12502516 DOI: 10.2337/Diabetes.52.1.214  0.473
2003 Legro RS, Urbanek M, Kunselman AR, Leiby BE, Dunaif A. Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated Obstetrical & Gynecological Survey. 58: 30-31. DOI: 10.1097/00006254-200301000-00018  0.495
2002 Li M, Youngren JF, Dunaif A, Goldfine ID, Maddux BA, Zhang BB, Evans JL. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. The Journal of Clinical Endocrinology and Metabolism. 87: 4088-93. PMID 12213853 DOI: 10.1210/Jc.2002-020363  0.387
2002 Legro RS, Urbanek M, Kunselman AR, Leiby BE, Dunaif A. Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated. Fertility and Sterility. 78: 51-7. PMID 12095490 DOI: 10.1016/S0015-0282(02)03153-9  0.418
2002 Legro RS, Kunselman AR, Demers L, Wang SC, Bentley-Lewis R, Dunaif A. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 87: 2134-2138. PMID 11994353 DOI: 10.1210/Jcem.87.5.8387  0.442
2002 Legro RS, Bentley-Lewis R, Driscoll D, Wang SC, Dunaif A. Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. The Journal of Clinical Endocrinology and Metabolism. 87: 2128-2133. PMID 11994352 DOI: 10.1210/Jcem.87.5.8513  0.537
2002 Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 87: 1017-23. PMID 11889155 DOI: 10.1210/Jcem.87.3.8305  0.404
2002 Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus Obstetrical & Gynecological Survey. 57: 356-357. DOI: 10.1097/00006254-200206000-00017  0.385
2001 Legro RS, Kunselman AR, Dunaif AE. Prevalence and predictors of dyslipidemia in Women with polycystic ovary syndrome The American Journal of Medicine. 111: 607-613. PMID 11755503 DOI: 10.1016/S0002-9343(01)00948-2  0.452
2001 Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS) American Journal of Physiology-Endocrinology and Metabolism. 281. PMID 11440917 DOI: 10.1152/Ajpendo.2001.281.2.E392  0.498
2001 Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 86: 1175-80. PMID 11238505 DOI: 10.1210/Jcem.86.3.7316  0.434
2001 Venkatesan AM, Dunaif A, Corbould A. Insulin resistance in polycystic ovary syndrome: Progress and paradoxes Recent Progress in Hormone Research. 56: 295-308. PMID 11237218 DOI: 10.1210/Rp.56.1.295  0.473
2001 Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annual Review of Medicine. 52: 401-419. PMID 11160786 DOI: 10.1146/Annurev.Med.52.1.401  0.519
2001 Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. The Journal of Clinical Investigation. 107: 181-9. PMID 11160134 DOI: 10.1172/Jci10934  0.329
2000 Urbanek M, Wu X, Vickery KR, Kao LC, Christenson LK, Schneyer A, Legro RS, Driscoll DA, Strauss JF, Dunaif A, Spielman RS. Allelic variants of the follistatin gene in polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 85: 4455-4461. PMID 11134093 DOI: 10.1210/Jcem.85.12.7026  0.34
2000 Martens JW, Geller DH, Arlt W, Auchus RJ, Ossovskaya VS, Rodriguez H, Dunaif A, Miller WL. Enzymatic activities of P450c17 stably expressed in fibroblasts from patients with the polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 85: 4338-46. PMID 11095477 DOI: 10.1210/Jcem.85.11.6971  0.415
2000 McDonald C, Dunaif A, Finegood DT. Minimal-model estimates of insulin sensitivity are insensitive to errors in glucose effectiveness. The Journal of Clinical Endocrinology and Metabolism. 85: 2504-2508. PMID 10902801 DOI: 10.1210/Jcem.85.7.6681  0.395
1999 Book CB, Dunaif A. Selective Insulin Resistance in the Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 84: 3110-3116. PMID 10487672 DOI: 10.1210/Jcem.84.9.6010  0.462
1999 Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF, Spielman RS, Dunaif A. Thirty-Seven Candidate Genes For Polycystic Ovary Syndrome : Strongest Evidence For Linkage Is With Follistatin Proceedings of the National Academy of Sciences of the United States of America. 96: 8573-8578. PMID 10411917 DOI: 10.1073/Pnas.96.15.8573  0.406
1999 Strauss JF, Dunaif A. Molecular mysteries of polycystic ovary syndrome. Molecular Endocrinology. 13: 800-805. PMID 10379878 DOI: 10.1210/Mend.13.6.0285  0.531
1999 Dunaif A. Insulin Action In The Polycystic Ovary Syndrome Endocrinology and Metabolism Clinics of North America. 28: 341-359. PMID 10352922 DOI: 10.1016/S0889-8529(05)70073-6  0.534
1999 Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women The Journal of Clinical Endocrinology and Metabolism. 84: 165-169. PMID 9920077 DOI: 10.1210/Jcem.84.1.5393  0.472
1999 Dunaif A, Legro RS. Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome—Authors’ Response1 The Journal of Clinical Endocrinology and Metabolism. 84: 2975-2977. DOI: 10.1210/Jcem.84.8.5939-4  0.303
1999 Legro RS, Dunaif A. Fasting Glucose to Insulin Ratio, or Product of Glucose and Insulin?—Authors’ Response The Journal of Clinical Endocrinology and Metabolism. 84: 383-383. DOI: 10.1210/Jcem.84.1.5427-4  0.397
1999 Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women Obstetrical & Gynecological Survey. 54: 385-386. DOI: 10.1097/00006254-199906000-00019  0.424
1999 Legro RS, Finegood D, Dunaif A. A Fasting Glucose To Insulin Ratio Is A Useful Measure Of Insulin Sensitivity In Women With Polycystic Ovary Syndrome Obstetrical & Gynecological Survey. 54: 35-36. DOI: 10.1097/00006254-199901000-00019  0.502
1998 Phillips RA, Krakoff LR, Dunaif A, Finegood DT, Gorlin R, Shimabukuro S. Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. The Journal of Clinical Endocrinology and Metabolism. 83: 4284-8. PMID 9851765 DOI: 10.1210/Jcem.83.12.5331  0.339
1998 Legro RS, Driscoll D, Strauss JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome Proceedings of the National Academy of Sciences of the United States of America. 95: 14956-14960. PMID 9843997 DOI: 10.1073/Pnas.95.25.14956  0.467
1998 Legro RS, Finegood D, Dunaif A. A Fasting Glucose to Insulin Ratio Is a Useful Measure of Insulin Sensitivity in Women with Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 83: 2694-2698. PMID 9709933 DOI: 10.1210/Jcem.83.8.5054  0.479
1998 Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, Cook D, Dunaif A. Development of a Health-Related Quality-of-Life Questionnaire (PCOSQ) for Women with Polycystic Ovary Syndrome (PCOS) The Journal of Clinical Endocrinology and Metabolism. 83: 1976-1987. PMID 9626128 DOI: 10.1210/Jcem.83.6.4990  0.37
1998 Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF, Dunaif A. Phenotype and genotype in polycystic ovary syndrome. Recent Progress in Hormone Research. 53: 217-256. DOI: 10.1017/Cbo9780511545191.003  0.514
1997 Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews. 18: 774-800. PMID 9408743 DOI: 10.1210/Edrv.18.6.0318  0.451
1997 Mantzoros CS, Dunaif A, Flier JS. Leptin Concentrations In The Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 82: 1687-1691. PMID 9177364 DOI: 10.1210/Jcem.82.6.4017  0.442
1997 Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome Obstetrical & Gynecological Survey. 52: 110-111. DOI: 10.1097/00006254-199702000-00016  0.468
1996 Diamanti-Kandarakis E, Dunaif A. New perspectives in polycystic ovary syndrome Trends in Endocrinology and Metabolism. 7: 267-271. PMID 18406758 DOI: 10.1016/S1043-2760(96)00125-7  0.521
1996 Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The Insulin-Sensitizing Agent Troglitazone Improves Metabolic and Reproductive Abnormalities in the Polycystic Ovary Syndrome* The Journal of Clinical Endocrinology and Metabolism. 81: 3299-3306. PMID 8784087 DOI: 10.1210/Jcem.81.9.8784087  0.512
1996 Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 81: 942-947. PMID 8772555 DOI: 10.1210/Jcem.81.3.8772555  0.517
1996 Legro RS, Dunaif A. The role of insulin resistance in polycystic ovary syndrome Endocrinologist. 6: 307-321. DOI: 10.1097/00019616-199607000-00007  0.459
1995 Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. The American Journal of Medicine. 98. PMID 7825639 DOI: 10.1016/S0002-9343(99)80057-6  0.542
1995 Dunaif A, Xia J, Book CB, Schenker E, Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. Journal of Clinical Investigation. 96: 801-810. PMID 7635975 DOI: 10.1172/Jci118126  0.443
1994 Weiss DJ, Charles MA, Dunaif A, Prior DE, Lillioja S, Knowler WC, Herman WH. Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women. Metabolism: Clinical and Experimental. 43: 803-7. PMID 8028500 DOI: 10.1016/0026-0495(94)90257-7  0.431
1994 Sorbara LR, Zhichun Tang, Cama A, Jinru Xia, Schenker E, Kohanski RA, Poretsky L, Koller E, Taylor SI, Dunaif A. Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome Metabolism. 43: 1568-1574. PMID 7990713 DOI: 10.1016/0026-0495(94)90018-3  0.474
1994 Dunaif A. Molecular mechanisms of insulin resistance in the polycystic ovary syndrome Seminars in Reproductive Endocrinology. 12: 15-20. DOI: 10.1055/S-2007-1016376  0.448
1993 Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes American Journal of Physiology-Endocrinology and Metabolism. 264. PMID 8447386 DOI: 10.1152/Ajpendo.1993.264.2.E197  0.503
1993 Dunaif A, Sorbara L, Delson R, Green G. Ethnicity and Polycystic Ovary Syndrome are Associated With Independent and Additive Decreases in Insulin Action in Caribbean-Hispanic Women Diabetes. 42: 1462-1468. PMID 8375585 DOI: 10.2337/Diab.42.10.1462  0.54
1993 Dunaif A. Insulin resistance in polycystic ovarian syndrome. Annals of the New York Academy of Sciences. 687: 60-64. PMID 8323191 DOI: 10.1111/J.1749-6632.1993.Tb43854.X  0.463
1993 Fox JH, Licholai T, Green G, Dunaif A. Differential effects of oral glucose-mediated versus intravenous hyperinsulinemia on circulating androgen levels in women * † Fertility and Sterility. 60: 994-1000. DOI: 10.1016/S0015-0282(16)56399-7  0.494
1993 Futterweit W, Green G, Tarlin N, Dunaif A. Chronic high‐dosage androgen administration to ovulatory women does not alter adrenocortical steroidogenesis International Journal of Gynecology & Obstetrics. 40: 269-270. DOI: 10.1016/0020-7292(93)90869-X  0.358
1992 Zimmermann S, Phillips RA, Dunaif A, Finegood DT, Wilkenfeld C, Ardeljan M, Gorlin R, Krakoff LR. Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. The Journal of Clinical Endocrinology and Metabolism. 75: 508-13. PMID 1639952 DOI: 10.1210/Jcem.75.2.1639952  0.491
1992 Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome Diabetes. 41: 1257-1266. PMID 1397698 DOI: 10.2337/Diab.41.10.1257  0.493
1992 Dunaif A. Insulin Resistance and Ovarian Hyperandrogenism Endocrinologist. 2: 248-260. DOI: 10.1097/00019616-199207000-00007  0.402
1992 Futterweit W, Green G, Tarlin N, Dunaif A. Chronic high-dosage androgen administration to ovulatory women does not alter adrenocortical steroidogenesis. Fertility and Sterility. 58: 124-128. DOI: 10.1016/S0015-0282(16)55148-6  0.311
1991 Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W, Lewy L. Acanthosis nigricans, insulin action, and hyperandrogenism : clinical, histological, and biochemical findings The Journal of Clinical Endocrinology and Metabolism. 73: 590-595. PMID 1874935 DOI: 10.1210/Jcem-73-3-590  0.493
1991 Graf MJ, Richards CJ, Brown V, Meissner L, Dunaif A. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women Obstetrical & Gynecological Survey. 46: 56-57. DOI: 10.1097/00006254-199101000-00018  0.352
1990 Poretsky L, Bhargava G, Saketos M, Dunaif A. Regulation of human ovarian insulin receptors in vivo Metabolism-Clinical and Experimental. 39: 161-166. PMID 2405234 DOI: 10.1016/0026-0495(90)90070-S  0.487
1990 Graf MJ, Richards CJ, Brown V, Meissner L, Dunaif A. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women Clinical Endocrinology. 33: 119-131. PMID 2205423 DOI: 10.1111/J.1365-2265.1990.Tb00472.X  0.457
1990 Dunaif A, Green G, Futterweit W, Dobrjansky A. Suppression of Hyperandrogenism Does not Improve Peripheral or Hepatic Insulin Resistance in the Polycystic Ovary Syndrome The Journal of Clinical Endocrinology and Metabolism. 70: 699-704. PMID 2106527 DOI: 10.1210/Jcem-70-3-699  0.482
1989 Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome Diabetes. 38: 1165-1174. PMID 2670645 DOI: 10.2337/Diab.38.9.1165  0.507
1989 Dunaif A, Graf M. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome. Journal of Clinical Investigation. 83: 23-29. PMID 2642919 DOI: 10.1172/Jci113864  0.517
1988 Dunaif A, Mandeli J, Fluhr H, Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism. 66: 131-139. PMID 2961783 DOI: 10.1210/Jcem-66-1-131  0.499
1988 Dunaif A, Mandeli J, Fluhr H, Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome Obstetrical & Gynecological Survey. 43: 688-690. DOI: 10.1097/00006254-198811000-00015  0.356
1987 Dunaif A, Tattersall I. Prevalence of glucose intolerance in free-ranging Macaca fascicularis of Mauritius. American Journal of Primatology. 13: 435-442. PMID 31973458 DOI: 10.1002/Ajp.1350130408  0.389
1987 Segal KR, Dunaif A, Gutin B, Albu J, Nyman A, Pi-Sunyer FX. Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men. Journal of Clinical Investigation. 80: 1050-1055. PMID 3654969 DOI: 10.1172/Jci113159  0.346
1987 Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of Groups of Hyperaiidrogenic Women with Acanthosis Nigricans, Impaired Glucose Tolerance, and/or Hyperinsulinemia The Journal of Clinical Endocrinology and Metabolism. 65: 499-507. PMID 3305551 DOI: 10.1210/Jcem-65-3-499  0.501
1986 Dunaif A. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome The Journal of Clinical Endocrinology and Metabolism. 63: 215-221. PMID 3086357 DOI: 10.1210/Jcem-63-1-215  0.311
1985 Dunaif A, Longcope C, Canick J, Badger T, Crowley WF. The effects of the aromatase inhibitor Δ1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease Journal of Clinical Endocrinology and Metabolism. 60: 773-780. PMID 3919053 DOI: 10.1210/Jcem-60-4-773  0.366
1985 Graf M, Dunaif A. Association of Reproductive Endocrine Dysfunction with Pelvic Endometriosis Seminars in Reproductive Medicine. 3: 319-327. DOI: 10.1055/S-2007-1022633  0.327
1984 Dunaif A, Scully RE, Andersen RN, Chapin DS, Crowley WF. The effects of continuous androgen secretion on the hypothalamic-pituitary axis in woman: evidence from a luteinized thecoma of the ovary. The Journal of Clinical Endocrinology and Metabolism. 59: 389-93. PMID 6086692 DOI: 10.1210/Jcem-59-3-389  0.34
Show low-probability matches.